Nexalin Technology (NASDAQ:NXL) vs. Positron (OTCMKTS:POSC) Financial Analysis

Nexalin Technology (NASDAQ:NXL) and Positron (OTCMKTS:POSC) are both small-cap business services companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, dividends, analyst recommendations and risk.

Profitability

This table compares Nexalin Technology and Positron’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nexalin Technology	-3,088.12%	-154.84%	-122.94%
Positron	-222.99%	N/A	-65.25%

Institutional and Insider Ownership

0.7% of Nexalin Technology shares are owned by institutional investors. 27.7% of Nexalin Technology shares are owned by company insiders. Comparatively, 17.2% of Positron shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Nexalin Technology and Positron, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nexalin Technology	0	0	0	0	N/A
Positron	0	0	0	0	N/A

Valuation & Earnings

This table compares Nexalin Technology and Positron’s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nexalin Technology	$110,000.00	96.60	-$4.65 million	($0.66)	-2.12
Positron	$740,000.00	47.30	-$1.64 million	N/A	N/A

Positron has higher revenue and earnings than Nexalin Technology.

Risk and Volatility

Nexalin Technology has a beta of 5.56, meaning that its stock price is 456% more volatile than the S&P 500. Comparatively, Positron has a beta of 0.59, meaning that its stock price is 41% less volatile than the S&P 500.

Summary

Positron beats Nexalin Technology on 5 of the 9 factors compared between the two stocks.

About Nexalin Technology

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.

About Positron

Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States. It offers attrius PET scanner, clinical and technical services, and financing solutions enables healthcare providers to accurately diagnose cardiac disease, improve patient outcomes, and practice cost effective medicines. Positron Corporation was incorporated in 1983 and is based in Niagara Falls, New York.